53.73 -0.54 (-0.99%)
GILD
| Trade GILD now with |
|
Stock Details
Last Trade:53.73 Change:-0.54 (-0.99%) Prev Close:54.27 Open: 54.39 Days Range:53.55 – 54.39 52 Week Range: 34.45 - 56.50 Volume:7872842 P/E: 15.14EPS:3.55
View AllRecent Alerts 02/09/12
Recent Alert on 02/08/12 at 11:26am
Alexion Pharmaceuticals (ALXN) Lower As Biotechs See Pressure
Alexion Pharmaceuticals (ALXN) Lower As Biotechs See Pressure
Alexion Pharmaceuticals, Inc. (Nasdaq: ALXN) is raising eyebrows today as shares are seeing notable weakness. The stock is down 3.6% mid-day although there is no news to explain the action. ALXN is not the only large biotech seeing weakness,... Read More
Recent Alert on 02/06/12 at 2:45pm
Notable 52-Week Highs and Lows of the Day 02/06: (THLD) (GILD) (AAPL) High; (CYDE) Low
Notable 52-Week Highs and Lows of the Day 02/06: (THLD) (GILD) (AAPL) High; (CYDE) Low
Recent Alert on 02/06/12 at 2:00pm
UBS Maintains a 'Buy' on Gilead Sciences (GILD); Raising PT on Lower Risk to HCV
UBS Maintains a 'Buy' on Gilead Sciences (GILD); Raising PT on Lower Risk to HCV
Recent Alert on 02/03/12 at 2:57pm
William Blair Lifts Target on Idenix (IDIX) to $14 Following Removal of Clinical Hold
William Blair Lifts Target on Idenix (IDIX) to $14 Following Removal of Clinical Hold
Recent Alert on 02/03/12 at 2:13pm
Notable 52-Week Highs and Lows of the Day 02/03: (GILD) (STX) (DVAX) High; (MNKD) (THQI) (XCO) Low
Notable 52-Week Highs and Lows of the Day 02/03: (GILD) (STX) (DVAX) High; (MNKD) (THQI) (XCO) Low
View AllRecent Press Releases
Press Release on 02/06/12 at 9:00am
Perception, Opportunity in Volatility - Research & Analysis on Zynga Inc and Gilead Sciences, Inc.
Perception, Opportunity in Volatility - Research & Analysis on Zynga Inc and Gilead Sciences, Inc.
View AllRecent SEC Filings
SEC Filing on 02/09/12 at 7:26pm
Form 4 GILEAD SCIENCES INC For: Feb 07 Filed by: Washington Robin L
Form 4 GILEAD SCIENCES INC For: Feb 07 Filed by: Washington Robin L
View AllRecent Blog Posts
Blog Posts on 02/07/12 at 3:18pm
5 Solid Biotechs That Have Delivered Positive Earnings Surprises Recently
5 Solid Biotechs That Have Delivered Positive Earnings Surprises Recently
Blog Posts on 02/07/12 at 2:36am
Top Q4 Buys And Sells Of Healthcare-Focused Hambrecht And Quist Capital Management
Top Q4 Buys And Sells Of Healthcare-Focused Hambrecht And Quist Capital Management